Cargando…

Decreased extra-renal urate excretion is a common cause of hyperuricemia

ABCG2, also known as BCRP, is a high-capacity urate exporter, the dysfunction of which raises gout/hyperuricemia risk. Generally, hyperuricemia has been classified into urate 'overproduction type' and/or 'underexcretion type' based solely on renal urate excretion, without conside...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ichida, Kimiyoshi, Matsuo, Hirotaka, Takada, Tappei, Nakayama, Akiyoshi, Murakami, Keizo, Shimizu, Toru, Yamanashi, Yoshihide, Kasuga, Hiroshi, Nakashima, Hiroshi, Nakamura, Takahiro, Takada, Yuzo, Kawamura, Yusuke, Inoue, Hiroki, Okada, Chisa, Utsumi, Yoshitaka, Ikebuchi, Yuki, Ito, Kousei, Nakamura, Makiko, Shinohara, Yoshihiko, Hosoyamada, Makoto, Sakurai, Yutaka, Shinomiya, Nariyoshi, Hosoya, Tatsuo, Suzuki, Hiroshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Pub. Group 2012
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3337984/ https://www.ncbi.nlm.nih.gov/pubmed/22473008 http://dx.doi.org/10.1038/ncomms1756

Ejemplares similares

Identification of GLUT12/SLC2A12 as a urate transporter that regulates the blood urate level in hyperuricemia model mice
por: Toyoda, Yu, et al.
Publicado: (2020)

Hyperuricemia in acute gastroenteritis is caused by decreased urate excretion via ABCG2
por: Matsuo, Hirotaka, et al.
Publicado: (2016)

ABCG2 dysfunction causes hyperuricemia due to both renal urate underexcretion and renal urate overload
por: Matsuo, Hirotaka, et al.
Publicado: (2014)

The effects of URAT1/SLC22A12 nonfunctional variants,R90H and W258X, on serum uric acid levels and gout/hyperuricemia progression
por: Sakiyama, Masayuki, et al.
Publicado: (2016)

Common variants of a urate-associated gene LRP2 are not associated with gout susceptibility
por: Nakayama, Akiyoshi, et al.
Publicado: (2013)

Common dysfunctional variants of ABCG2 have stronger impact on hyperuricemia progression than typical environmental risk factors
por: Nakayama, Akiyoshi, et al.
Publicado: (2014)

Substantial anti-gout effect conferred by common and rare dysfunctional variants of URAT1/SLC22A12
por: Toyoda, Yu, et al.
Publicado: (2021)

OAT10/SLC22A13 Acts as a Renal Urate Re-Absorber: Clinico-Genetic and Functional Analyses With Pharmacological Impacts
por: Toyoda, Yu, et al.
Publicado: (2022)

Common dysfunctional variants in ABCG2 are a major cause of early-onset gout
por: Matsuo, Hirotaka, et al.
Publicado: (2013)

Vitamin C transporter SVCT1 serves a physiological role as a urate importer: functional analyses and in vivo investigations
por: Toyoda, Yu, et al.
Publicado: (2023)

Immunohistochemical and in situ hybridization study of urate transporters GLUT9/URATv1, ABCG2, and URAT1 in the murine brain
por: Tomioka, Naoko H., et al.
Publicado: (2016)

Ependymal cells of the mouse brain express urate transporter 1 (URAT1)
por: Tomioka, Naoko H, et al.
Publicado: (2013)

Dysfunctional ABCG2 gene polymorphisms are associated with serum uric acid levels and all-cause mortality in hemodialysis patients
por: Nakashima, Akio, et al.
Publicado: (2020)

Genetic epidemiological analysis of hypouricaemia from 4993 Japanese on non-functional variants of URAT1/SLC22A12 gene
por: Nakayama, Akiyoshi, et al.
Publicado: (2021)

Familial early-onset hyperuricemia and gout associated with a newly identified dysfunctional variant in urate transporter ABCG2
por: Toyoda, Yu, et al.
Publicado: (2019)

Identification of Febuxostat as a New Strong ABCG2 Inhibitor: Potential Applications and Risks in Clinical Situations
por: Miyata, Hiroshi, et al.
Publicado: (2016)

NPC1L1 Facilitates Sphingomyelin Absorption and Regulates Diet-Induced Production of VLDL/LDL-associated S1P
por: Yamanashi, Yoshihide, et al.
Publicado: (2020)

Pathophysiological importance of bile cholesterol reabsorption: hepatic NPC1L1-exacerbated steatosis and decreasing VLDL-TG secretion in mice fed a high-fat diet
por: Toyoda, Yu, et al.
Publicado: (2019)

Identification of Two Dysfunctional Variants in the ABCG2 Urate Transporter Associated with Pediatric-Onset of Familial Hyperuricemia and Early-Onset Gout
por: Toyoda, Yu, et al.
Publicado: (2021)

GWAS of clinically defined gout and subtypes identifies multiple susceptibility loci that include urate transporter genes
por: Nakayama, Akiyoshi, et al.
Publicado: (2017)

A common missense variant of monocarboxylate transporter 9 (MCT9/SLC16A9) gene is associated with renal overload gout, but not with all gout susceptibility
por: Nakayama, Akiyoshi, et al.
Publicado: (2013)

Multiple common and rare variants of ABCG2 cause gout
por: Higashino, Toshihide, et al.
Publicado: (2017)

Identification of a dysfunctional splicing mutation in the SLC22A12/URAT1 gene causing renal hypouricaemia type 1: a report on two families
por: Kawamura, Yusuke, et al.
Publicado: (2020)

Inhibitory effect of Citrus flavonoids on the in vitro transport activity of human urate transporter 1 (URAT1/SLC22A12), a renal re-absorber of urate
por: Toyoda, Yu, et al.
Publicado: (2020)

A common variant of leucine-rich repeat-containing 16A (LRRC16A) gene is associated with gout susceptibility
por: Sakiyama, Masayuki, et al.
Publicado: (2013)

Omega-3 Polyunsaturated Fatty Acids Inhibit the Function of Human URAT1, a Renal Urate Re-absorber
por: Saito, Hiroki, et al.
Publicado: (2020)

A common variant of LDL receptor related protein 2 (LRP2) gene is associated with gout susceptibility: a meta-analysis in a Japanese population
por: Akashi, Airi, et al.
Publicado: (2020)

Identification of Inhibitory Activities of Dietary Flavonoids against URAT1, a Renal Urate Re-Absorber: In Vitro Screening and Fractional Approach Focused on Rooibos Leaves
por: Toyoda, Yu, et al.
Publicado: (2022)

A Proposal for Practical Diagnosis of Renal Hypouricemia: Evidenced from Genetic Studies of Nonfunctional Variants of URAT1/SLC22A12 among 30,685 Japanese Individuals
por: Kawamura, Yusuke, et al.
Publicado: (2021)

Clinical practice guideline for renal hypouricemia (1st edition)
por: Nakayama, Akiyoshi, et al.
Publicado: (2019)

Transporters for the Intestinal Absorption of Cholesterol, Vitamin E, and Vitamin K
por: Yamanashi, Yoshihide, et al.
Publicado: (2017)

SVCT2/SLC23A2 is a sodium-dependent urate transporter: functional properties and practical application
por: Toyoda, Yu, et al.
Publicado: (2023)

Identification of hepatic NPC1L1 as an NAFLD risk factor evidenced by ezetimibe‐mediated steatosis prevention and recovery
por: Toyoda, Yu, et al.
Publicado: (2019)

VLDL/LDL acts as a drug carrier and regulates the transport and metabolism of drugs in the body
por: Yamamoto, Hideaki, et al.
Publicado: (2017)

A meta-analysis of genome-wide association studies using Japanese and Taiwanese has revealed novel loci associated with gout susceptibility
por: Chang, Shun-Jen, et al.
Publicado: (2022)

ABCG5 and ABCG8 Are Involved in Vitamin K Transport
por: Matsuo, Michinori, et al.
Publicado: (2023)

What lies behind serum urate concentration? Insights from genetic and genomic studies
por: Ichida, Kimiyoshi
Publicado: (2009)

Effects of Osthol Isolated from Cnidium monnieri Fruit on Urate Transporter 1
por: Tashiro, Yuusuke, et al.
Publicado: (2018)

Genome-wide association study of clinically defined gout identifies multiple risk loci and its association with clinical subtypes
por: Matsuo, Hirotaka, et al.
Publicado: (2016)

Dysfunctional missense variant of OAT10/SLC22A13 decreases gout risk and serum uric acid levels
por: Higashino, Toshihide, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_d8anjob90ijbr7nmva6bjpgho1